Indonesian Journal of Administrative and Clinical Pharmacy
Vol. 1 No. 1 (2024): IJAClinPharm June

Clinical Evaluation of The Radiopharmaceutical 99mTc-Ethambutol to Diagnose Pulmonary and Extra-pulmonary Tuberculosis – Case Series

Wirabrata I Gede Made (a:1:{s:5:"en_US"
s:23:"University of Pancasila"
})

Achmad Hussein Sundawa Kartamihardja (Departement of Nuclear Medicine and Molecular Theranostic, Universitas Padjadjaran, Bandung, Jawa Barat)
Syamsudin Abdillah (Faculty of Pharmacy, Universitas Pancasila, Jakarta, Indonesia)
Yusi Anggriani (Center for Pharmaceutical Policy and Service Studies, Universitas Pancasila, Jakarta, Indonesia)
Hendig Winarno (National Atomic Energy, National Research and Innovation Agency, Jakarta, Indonesia)



Article Info

Publish Date
28 Jun 2024

Abstract

Infectious tuberculosis disease is caused by Mycobacterium tuberculosis and can infect the lungs as well as other organs (extrapulmonary). Advanced diagnosis of TB disease using nuclear medicine methods involves the use of the radiopharmaceutical 99mTc-ethambutol. This study aims to clinically evaluate 99mTc-ethambutol for diagnosing both pulmonary and extrapulmonary TB. Research methodology is clinical scientific research based on the disciplines of nuclear medicine and nuclear pharmacy in marketing surveillance of new drugs. The research period was in 2023, conducted at multiple centers across three hospitals with a sample of 22 serial post-marketing surveillance cases. The examination results for TB in the subjects using the ethambutol patch test showed positive results in 40.9% and negative results in 59.1%. Comparative tests of the ethambutol patch test against treatment outcomes using X-ray methods yielded positive results in 40.9% and negative results in 59.1%, and using culture methods yielded positive results in 27.3% and negative results in 72.7%. The comparative results of TB examinations using the three methods showed the same results and were compared with treatment outcomes, with 6 subjects testing positive for TB, 13 subjects testing negative for TB, and 3 subjects with positive results being cases of extrapulmonary TB. All subjects diagnosed with TB underwent treatment. The measurements of the ethambutol patch test method using scintigraphy showed a sensitivity of 100%, specificity of 100%, and accuracy of 100%. The study concluded that the clinical evaluation of 99mTc-ethambutol can be used to diagnose both pulmonary and extrapulmonary TB. No drug side effects or subject complaints were found before or after the injection of 99mTc-ethambutol. Recommended to continue clinical evaluation with a larger number of subjects.

Copyrights © 2024






Journal Info

Abbrev

IJACP

Publisher

Subject

Health Professions Public Health

Description

The Indonesian Journal of Administrative and Clinical Pharmacy (IJAClinPharm) was established in response to the need for comprehensive and up-to-date knowledge in these fields. The background for the founding of this journal includes several key factors: Advancement of Knowledge, the fields of ...